Press release
Alzheimer’s Drugs Market Developed Nations Witnessing High Growth on account of Increasing Occurrence of Neurodegenerative Diseases
Request a Brochure of the Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1245
According to Transparency Market Research, the global market opportunity for Alzheimer’s drugs is expected to scale to US$6.4 bn by 2025 after being worth US$3.6 bn in 2017, exhibiting a CAGR of 7.5% between 2017 and 2025. By geography, it is anticipated that North America will continue to remain in its leading position even in the years to come on account of the presence of several leading players. The presence of prominent players in the region has helped in easy distribution of treatment channels thereby helping the market to grow in this region. The North American Alzheimer’s drugs market is expected to rise from US$1.7 bn in 2017 to reach an evaluation of US$3 bn by 2025, expanding at a CAGR of 7.3% from 2017 to 2025. The report predicts that the Asia Pacific Alzheimer’s drugs Market will expand at the highest pace, exhibiting an 8.6% CAGR between 2017 and 2025. The market in Asia Pacific is estimated to be worth US$2.3 bn in 2025 after being worth US$1.1 bn in 2017.
Combined Drug Therapy and Memantine to Make Significant Contribution to Revenues
On the basis of drug class, it is expected that memantine which led in the past will continue to do so in the years to come. TMR also predicts that combined drug treatment will also contribute significantly to the revenue of the global Alzheimer’s drugs market in the coming years on account of the increasing realization and awareness about the efficiency of combined therapy. The increasing availability of combined therapy is also expected to be a reason behind its increased demand.
Request a Sample of the Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1245
Support Received from Governments in Developed Nations to Drive Growth of Alzheimer’s Drugs Market
One of the most important factors boosting the growth of the global Alzheimer’s drugs market is the increasing prevalence of this disease among the elderly in the developed nations in the West. This market also receives a healthy support from governments across developed nations on account of the rising occurrence of neurodegenerative diseases in these nations. This in turn has led to the development of new drugs and therapies which has helped in the development and growth of the global Alzheimer’s drugs market subsequently. The atmosphere is especially conducive for the Alzheimer’s drugs market in North America. In addition to this, the increasing awareness about neurodegenerative diseases among the developing nations and Asia Pacific will also fuel the growth of the global Alzheimer’s drugs market in the years to come.
High Cost of Advanced Drugs to Restrict the Growth of Market in Cost-sensitive Countries in Asia Pacific
As a result of limited awareness about Alzheimer’s disease in several countries in the southeast of Asia, the research infrastructure in this part of the world remains underdeveloped for Alzheimer’s. In addition to this the high cost of advanced drugs for the treatment of Alzheimer’s has also deterred the cost sensitive regions and underdeveloped nations in Asia Pacific from adopting these drugs. On a bright side however, things are changing and governments are increasingly supporting mental care infrastructure across several developing nations of Asia Pacific and this is expected to overcome the impact of the above mentioned restraint and help the market to grow in this region in the years to come.
The information in this preview comes from a Transparency Market Research report titled ‘Alzheimer’s Drugs Market (Drug class – Cholinergic, Memantine, and Combined Drug; Distribution Channel – Hospital Pharmacy, Retail Pharmacy, and Online Sales) – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 – 2025.’
About Us
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.
Contact Us
Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Alzheimer’s Drugs Market Developed Nations Witnessing High Growth on account of Increasing Occurrence of Neurodegenerative Diseases here
News-ID: 1169353 • Views: …
More Releases from Transparency Market Research
Oligonucleotide Therapeutics Market Size, Status, Scope and Growth Prospects 202 …
Global Oligonucleotide Therapeutics Market: Overview
Oligonucleotides refer to short chain DNA or RNA that are generally made by using automated synthesizers. In addition, purification of oligonucleotide is accomplished by anion exchange chromatography and it is followed by the techniques of freezing and desalting. In addition, synthesis of siRNA duplex oligonucleotide is done through an annealing step in which two purified strands of oligonucleotide are brought closer together in an equimolar ratio.…
Seasonal Affective Disorder Therapeutics Market Size, Status, Scope and Growth P …
Global Seasonal Affective Disorder Therapeutics Market: Overview
From 2020 to 2030, the global seasonal affective disorder is set to witness new profitable avenues. It is set to chart growth at a sturdy rate, compounded annually, with massive contributions coming from the North American region. On the other hand, Asia Pacific is anticipated to grow at an impressive CAGR.
Transparency Market Research notes that various factors are contributing towards the projected growth. These…
Esthetic Lasers and Energy Devices Market set to witness surge in demand over th …
In the past few years, the cosmetic industry has found new bioactive and high potency ingredients, which offer noticeable skin benefits to consumers. Various technological advancements in the esthetic industry, increase in disposable income, surge in awareness about skin rejuvenation & appearance are the major factors driving demand for esthetic procedures in developed as well as developing markets. The trend of adoption of innovative and advanced surgical devices in the…
Image Guided Surgery Devices Market Analysis and Research Report by Experts 2025
The global image guided surgery devices market is directly reliant on the development of healthcare across various regional longitudes of the world. As the healthcare industry make rapid advancements across a number of its sub-domains, the market for global image guided surgery devices would see the entry of new players into the market. The competition is expected to intensify in the coming years and wreak the need for proper strategizing…
More Releases for Alzheimer’s
Increasing Global Prevalence of Alzheimer’s and Improvising Regulatory Scenari …
Alzheimer’s disease is a neurodegenerative disorder that causes slow decline in abilities such as thinking, reasoning, and routine daily activities, alongside memory loss. This may lead to planning or solving problems, poor judgment, lack of social activities, and personality and mood changes, which are considered the most common symptoms of Alzheimer’s disease. Symptoms of Alzheimer’s disease generally begin to appear in patients in their mid-sixties. As per World Alzheimer’s report,…
Media Advisory: Alzheimer’s Disease Resource Center, Inc. Presents 10th Annual …
Who: Mary Ann Malack-Ragona, Executive Director/Chief Executive Officer, Alzheimer’s Disease Resource Center, Inc. (ADRC)
Participating Walk for Alzheimer’s teams and individuals
Mickey B, Radio Personality, WGBB Radio and Master of Ceremonies
Ronald McDonald
The Liberty Bells, USO troupe
What: Alzheimer’s Disease Resource Center, Inc. (ADRC) is presenting its 10th Annual Old Bethpage Walk for Alzheimer’s & Mexican Fiesta. There will be an opening ceremony with Mickey B, Radio Personality, WGBB Radio, as the Master of…
Home Care Assistance Partners with the Alzheimer’s Association to Promote Earl …
(Palo Alto, CA – November 29, 2011) Home Care Assistance, North America’s leading provider of in-home care for seniors, announced today that, along with companies including Genworth, Starbucks, Intel and Pfizer, they are now a Champion Partner of the Alzheimer’s Early Detection Alliance (AEDA). The AEDA is a program renowned for raising Alzheimer’s awareness and promoting early detection of the disease. As a member of this important alliance, Home…
Alzheimer’s Association Long Island Announces Release of Latest Report on Alzh …
Alzheimer’s Association Long Island announced the release of the most recent report about Alzheimer’s disease. “Alzheimer’s from the Frontlines: Challenges a National Alzheimer’s Plan Must Address” provides a look into the unrelenting challenges brought on by this disease by offering insights and perspectives from individuals across the country who participated in the Alzheimer’s Association’s public input process. The Association and over 70 of its chapters hosted 132 input sessions throughout…
Otava Alzheimer’s Disease Targeted Libraries
Alzheimer’s disease (AD) is a devastating and always fatal neurodegenerative disorder characterized by progressive impairment of cognitive function and emotional disturbances. Currently, more than 25 million people worldwide live with AD. But there is no cure for AD and no treatment to reverse its progression, there are medicines available that can help treat symptoms in some people with this disease. Intensive scientific research around the world brings us closer to…
Alzheimer’s Association Long Island Presents Public Input Session for National …
On August 24, Alzheimer’s Association Long Island will hold a public input session to solicit views, comments and perspectives from stakeholders in the Alzheimer’s community to assist in the development of a successful National Alzheimer’s Plan. The recommendations and comments expressed during these input sessions, taking place across the country in August, will be collected and shared this fall with officials from the U.S. Department of Health and Human Services,…
